Mortimer Ianinsider trades

In SEC Form 4 filings, Mortimer Ian is listed as PRESIDENT & CEO of Xenon Pharmaceuticals Inc. (XENE). In the last 90 days, Mortimer Ian bought $1.12M of Xenon Pharmaceuticals Inc. (XENE) on the open market and sold none. The purchase was $1.12M of Xenon Pharmaceuticals Inc. (XENE) on Sep 30. Took part in a cluster buy; the latest at Xenon Pharmaceuticals Inc. (XENE), where 2 insiders bought within 1 day, ending Sep 30.

Companies and roles

Company	Role	Transactions	Last filed
XENEXenon Pharmaceuticals Inc.	PRESIDENT & CEO	1	Oct 1

Cluster buys

XENE: 2 insiders bought $1.68M between Sep 30.

Form 4 historysince 2026-10-01

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
XENEXenon Pharmaceuticals Inc.	Sep 30	Oct 1	P	30,000	$37.38	Purchase +$1,121,400	49,923	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.